Abstract
Cancer cell-specific synthetic lethal interactions entail promising therapeutic possibilities. In this issue of Cancer Cell, Pfister et al. describe a synthetic lethal interaction where cancer cells deficient in H3K36me3 owing to SETD2 loss-of-function mutation are strongly sensitized to inhibition of WEE1, a cell cycle controlling kinase.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Cancer Cell |
Vol/bind | 28 |
Udgave nummer | 5 |
Sider (fra-til) | 545-547 |
Antal sider | 3 |
ISSN | 1535-6108 |
DOI | |
Status | Udgivet - 9 nov. 2015 |